-transparent.png){kind=logo}
We have conducted a retrospective study of high-dose folinic acid and 5-fluorouracil in 96 patients with advanced colorectal cancer. Patients received 200 mg m-2 (maximum 300-350 mg) folinic acid by infusion over 2 h followed by an i.v. bolus of 5-fluorouracil 400 mg m-2 then an infusion of 5-fluorouracil 600 mg m-2 over 22 h. This was repeated over the next 24 h. The schedule was given every 2 weeks for four cycles; thereafter patients with objective response continued to a maximum of eight cycles. The overall response rate was 10.6% in 85 evaluable patients. The median duration of response was 11 months. The median survival was 6 months. Toxicity was low, only one patient experiencing toxicity greater than WHO grade II (grade IV platelet toxicity). Diarrhoea, nausea, vomiting and mucositis also occurred but were mild and infrequent. Our low response rate may be related to factors such as patient characteristics or duration of treatment.
C L Hanna, and
F E McKinna, and
L B Williams, and
D Morrey, and
M Adams, and
M D Mason, and
T S Maughan
September 1988,
European journal of cancer & clinical oncology,
C L Hanna, and
F E McKinna, and
L B Williams, and
D Morrey, and
M Adams, and
M D Mason, and
T S Maughan
October 1995,
Cancer,
C L Hanna, and
F E McKinna, and
L B Williams, and
D Morrey, and
M Adams, and
M D Mason, and
T S Maughan
March 1991,
Annals of oncology : official journal of the European Society for Medical Oncology,
C L Hanna, and
F E McKinna, and
L B Williams, and
D Morrey, and
M Adams, and
M D Mason, and
T S Maughan
January 2012,
Asian Pacific journal of cancer prevention : APJCP,
C L Hanna, and
F E McKinna, and
L B Williams, and
D Morrey, and
M Adams, and
M D Mason, and
T S Maughan
July 1986,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
C L Hanna, and
F E McKinna, and
L B Williams, and
D Morrey, and
M Adams, and
M D Mason, and
T S Maughan
January 1988,
Cancer investigation,
C L Hanna, and
F E McKinna, and
L B Williams, and
D Morrey, and
M Adams, and
M D Mason, and
T S Maughan
January 1997,
Anticancer research,
C L Hanna, and
F E McKinna, and
L B Williams, and
D Morrey, and
M Adams, and
M D Mason, and
T S Maughan
January 1988,
Cancer investigation,
C L Hanna, and
F E McKinna, and
L B Williams, and
D Morrey, and
M Adams, and
M D Mason, and
T S Maughan
January 1993,
European journal of cancer (Oxford, England : 1990),
C L Hanna, and
F E McKinna, and
L B Williams, and
D Morrey, and
M Adams, and
M D Mason, and
T S Maughan
May 1992,
Cancer research,
